Results-oriented professional with more than 30 years of biopharma and medical device industry experience, including founding a public biotech company (BioVie Inc.). Managed all operational areas including clinical development program, financial management, manufacturing, intellectual property, KOL advisory board, website, and publications. Presented BioVie to investors and analysts and raised $18 million to up-list to the Nasdaq (ticker: “BIVI”). Prior to BioVie, played a key role at Searle Pharmaceuticals in globally launching the blockbuster drug Celebrex. Assisted with launch materials for dozens of new drugs and medical devices across many therapeutic areas and trained and managed sales representatives. Roll-up-the-sleeves team player.